Euro

Eurofarma is a leading Brazilian multinational pharmaceutical company with a significant presence across Latin America and a growing global footprint. The company operates across several segments, including prescription drugs, over-the-counter (OTC) medicines, generics, hospital supplies, and oncology treatments. Eurofarma is recognized for its heavy investment in innovation and R&D, maintaining a robust pipeline of both incremental and radical innovations, including biosimilars and complex small molecules. With a portfolio covering over 400 molecules and 700 products, the company serves nearly all medical specialties and is a key player in the regional healthcare ecosystem.